Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 21, Issue 5

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 21, Issue 5 (2012)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 21, Issue 5 (2012)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Volume 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Research Article

Article

Related articles

Page: 1

Published online: 12 Apr 2012

32 Views
0 CrossRef citations
0Altmetric

Editorial

Sulfasalazine for brain cancer fits

Harald Sontheimer PhD & Richard J Bridges PhD

Pages: 575-578

Published online: 12 Mar 2012

AbstractforSulfasalazine for brain cancer fits | Full Text | References | PDF (292 KB)

1560 Views
31 CrossRef citations
0Altmetric

Free Access

Editorial

Norgestrel may be a potential therapy for retinal degenerations

Francesca Doonan & Thomas G Cotter

Pages: 579-581

Published online: 01 Mar 2012

AbstractforNorgestrel may be a potential therapy for retinal degenerations | Full Text | References | PDF (163.2 KB)

986 Views
12 CrossRef citations
0Altmetric

Free Access

Letter to the Editor

Letter

A bright future of researching AMPA receptor agonists for depression treatment

Chun Yang, Wei Zhou, Xiaomin Li, Jianjun Yang, Bernadeta Szewczyk, Agnieszka Pałucha-Poniewiera, Ewa Poleszak, Andrzej Pilc & Gabriel Nowak

Pages: 583-585

Published online: 01 Mar 2012

First Page PreviewforA bright future of researching AMPA receptor agonists for depression treatment | Full Text | References | PDF (152.8 KB)

1760 Views
2 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Targeting of polo-like kinases and their cross talk with Aurora kinases – possible therapeutic strategies in human acute myeloid leukemia?

Galina Tsykunova, Håkon Reikvam, Aymen Bushra Ahmed, Ina Nepstad, Bjørn Tore Gjertsen & Øystein Bruserud

Pages: 587-603

Published online: 17 Mar 2012

AbstractforTargeting of polo-like kinases and their cross talk with Aurora kinases – possible therapeutic strategies in human acute myeloid leukemia? | Full Text | References | PDF (251.3 KB)

502 Views
20 CrossRef citations
0Altmetric

Review Article

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

Katharina Seystahl & Michael Weller MD

Pages: 605-617

Published online: 13 Mar 2012

AbstractforIs there a world beyond bevacizumab in targeting angiogenesis in glioblastoma? | Full Text | References | PDF (342.4 KB)

457 Views
21 CrossRef citations
0Altmetric

Review Article

Recent advances on structural modifications of benzothiazoles and their conjugate systems as potential chemotherapeutics

Kamal Ahmed, Srikanth Yellamelli Valli Venkata, Naseer Ahmed Khan Mohammed, Farheen Sultana & Kashi Reddy Methuku

Pages: 619-635

Published online: 12 Apr 2012

AbstractforRecent advances on structural modifications of benzothiazoles and their conjugate systems as potential chemotherapeutics | Full Text | References | PDF (438 KB)

242 Views
28 CrossRef citations
0Altmetric

Review Article

JAK2 inhibition for the treatment of hematologic and solid malignancies

Brian L Harry BS, S. Gail Eckhardt MD & Antonio Jimeno MD PhD

Pages: 637-655

Published online: 12 Apr 2012

AbstractforJAK2 inhibition for the treatment of hematologic and solid malignancies | Full Text | References | PDF (257.3 KB)

500 Views
23 CrossRef citations
0Altmetric

Review Article

Investigational ABC transporter inhibitors

Marco Falasca & Kenneth J. Linton

Pages: 657-666

Published online: 12 Apr 2012

AbstractforInvestigational ABC transporter inhibitors | Full Text | References | PDF (222.8 KB)

1385 Views
88 CrossRef citations
0Altmetric

Review Article

Inhibition of pre-protein convertase serine kexin-9 (PCSK-9) as a treatment for hyperlipidaemia

Anthony S Wierzbicki DM DPhil FRCPath FAHA, Timothy C Hardman PhD & Adie Viljoen MBBS FRCPath

Pages: 667-676

Published online: 12 Apr 2012

AbstractforInhibition of pre-protein convertase serine kexin-9 (PCSK-9) as a treatment for hyperlipidaemia | Full Text | References | PDF (215.6 KB)

983 Views
33 CrossRef citations
0Altmetric

Review Article

New frontiers in female contraception (and male condoms): 2012

Anita L Nelson MD

Pages: 677-693

Published online: 12 Apr 2012

AbstractforNew frontiers in female contraception (and male condoms): 2012 | Full Text | References | PDF (276.6 KB)

426 Views
0 CrossRef citations
0Altmetric

Drug Evaluations

Article

A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection

Tanuja N Gengiah MClin Pharm MS (Epi), Cheryl Baxter MSc, Leila E Mansoor PhD, Ayesha BM Kharsany PhD & Salim. S Abdool Karim MBChB PhD

Pages: 695-715

Published online: 07 Mar 2012

AbstractforA drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection | Full Text | References | PDF (398.4 KB)

344 Views
22 CrossRef citations
0Altmetric

Article

ENMD-2076 for hematological malignancies

Jonathan How & Karen Yee MDCM FRCP(C)

Pages: 717-732

Published online: 08 Mar 2012

Abstractfor ENMD-2076 for hematological malignancies | Full Text | References | PDF (274.2 KB)

238 Views
9 CrossRef citations
0Altmetric

Article

Panobinostat for the treatment of multiple myeloma

Paola Neri, Nizar J Bahlis & Sagar Lonial

Pages: 733-747

Published online: 12 Mar 2012

Abstractfor Panobinostat for the treatment of multiple myeloma | Full Text | References | PDF (528.3 KB)

798 Views
33 CrossRef citations
0Altmetric

Article

Glufosfamide: can we improve the process of anticancer agent development?

Denis Lacombe

Pages: 749-754

Published online: 16 Mar 2012

Abstractfor Glufosfamide: can we improve the process of anticancer agent development? | Full Text | References | PDF (248.9 KB)

200 Views
12 CrossRef citations
0Altmetric

Article

EC145: a novel targeted agent for adenocarcinoma of the lung

Pamela Pribble MD & Martin J Edelman MD

Pages: 755-761

Published online: 30 Mar 2012

Abstractfor EC145: a novel targeted agent for adenocarcinoma of the lung | Full Text | References | PDF (199.3 KB)

515 Views
31 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Novel investigational drugs for alopecia areata and future perspectives

Ivana Chim et al.

Review Article | Published online: 29 Apr 2024

Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study

Jiaming Gao et al.

Review Article | Published online: 27 Apr 2024

Investigational farnesoid X receptor agonists for the treatment of primary biliary cholangitis

Prithvi Reddy Akepati et al.

Review Article | Published online: 27 Apr 2024

Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?

Gabrio Bassotti

Editorial | Published online: 25 Apr 2024

Free Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.21, Iss.5, 2012)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?